Location: London, United Kingdom
CIK: 0001889830 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 13, 2026
Total Value: $352M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HAYW | HAYWARD HLDGS INC | 6,572,676 | $87.94M | 24.9% | $13.83 | +17.7% | COM | 421298100 |
| RVMD | REVOLUTION MEDICINES INC | 795,733 | $77.39M | 22.0% | $52.53 | +96.1% | COM | 76155X100 |
| KLAR | KLARNA GROUP PLC | 2,714,928 | $35.54M | 10.1% | $42.59 | -44.9% | SHS | G5279N105 |
| RXRX | RECURSION PHARMACEUTICALS IN | 9,644,032 | $29.61M | 8.4% | $8.44 | -50.5% | CL A | 75629V104 |
| QSR | RESTAURANT BRANDS INTL INC | 386,203 | $28.54M | 8.1% | $58.94 | +16.0% | COM | 76131D103 |
| CPNG | COUPANG INC | 1,412,946 | $26.68M | 7.6% | $28.16 | -29.5% | CL A | 22266T109 |
| META | META PLATFORMS INC | 33,300 | $19.05M | 5.4% | $217.59 | +201.3% | CL A | 30303M102 |
| GRAB | GRAB HOLDINGS LIMITED | 5,000,000 | $18.3M | 5.2% | $3.41 | +31.7% | CLASS A ORD | G4124C109 |
| NMRA | NEUMORA THERAPEUTICS INC. | 4,460,700 | $8.698M | 2.5% | $12.87 | -80.9% | COM | 640979100 |
| INSG | INSEEGO CORP | 767,165 | $8.531M | 2.4% | $11.06 | 0.0% | COM NEW | 45782B302 |
| MNDY | MONDAY COM LTD | 66,000 | $4.561M | 1.3% | $247.55 | -55.8% | SHS | M7S64H106 |
| ACHR | ARCHER AVIATION INC | 700,000 | $3.619M | 1.0% | $4.03 | +93.2% | COM CL A | 03945R102 |
| RKLB | ROCKET LAB CORP | 35,628 | $2.288M | 0.6% | $79.27 | 0.0% | COM | 773121108 |
| LYEL | LYELL IMMUNOPHARMA INC | 87,028 | $1.746M | 0.5% | $9.11 | +167.0% | COM NEW | 55083R203 |